Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Back to team page
Christina Ambrose
Director
With a background in interdisciplinary social sciences, Christina has been trained in various qualitative research methods. Her human factors expertise includes consulting on products from early-stage exploratory research through end stage validation studies, and she has supported several successful submissions. She collaborates with clients to design programs of research and decide on optimal methodologies, while supervising individual research projects involving medical devices and digital health management platforms. Christina holds a BA in Comparative Human Development and an MA in the Social Sciences from the University of Chicago.
Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:
In your spare time (or if you had spare time), you would absolutely do this:

Your favorite city in the world is...and why?
You cannot start the day without doing this:

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?
Any other facts to share?
Read our team’s latest bold insights
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.